Cite
High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites
MLA
Elfrink, Suraya, et al. “High Frequency of Inactivating Tetraspanin CD37 Mutations in Diffuse Large B-Cell Lymphoma at Immune-Privileged Sites.” Blood, vol. 134, no. 12, Sept. 2019, pp. 946–50. EBSCOhost, https://doi.org/10.1182/blood.2019001185.
APA
Elfrink, S., de Winde, C. M., van den Brand, M., Berendsen, M., Roemer, M. G. M., Arnold, F., Janssen, L., van der Schaaf, A., Jansen, E., Groenen, P. J. T. A., Eijkelenboom, A., Stevens, W., Hess, C. J., van Krieken, J. H., Vermaat, J. S. P., Cleven, A. H. G., de Groen, R. A. L., Neviani, V., de Jong, D., … van Spriel, A. B. (2019). High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites. Blood, 134(12), 946–950. https://doi.org/10.1182/blood.2019001185
Chicago
Elfrink, Suraya, Charlotte M. de Winde, Michiel van den Brand, Madeleine Berendsen, Margaretha G. M. Roemer, Frank Arnold, Luuk Janssen, et al. 2019. “High Frequency of Inactivating Tetraspanin CD37 Mutations in Diffuse Large B-Cell Lymphoma at Immune-Privileged Sites.” Blood 134 (12): 946–50. doi:10.1182/blood.2019001185.